[Systemic therapy of metastatic malignant melanoma].
Stahel
R A
RA
Martz
G
G
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003606:Dacarbazine / Q000008:administration & dosage; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007370:Interferon Type I / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D007694:Killer Cells, Natural / Q000276:immunology; D008130:Lomustine / Q000008:administration & dosage; D008545:Melanoma / Q000556:secondary / Q000628:therapy*; D012878:Skin Neoplasms / Q000556:secondary / Q000628:therapy*
D007370:Interferon Type I; D007376:Interleukin-2; D008130:Lomustine; D003606:Dacarbazine
Systemtherapie des metastasierenden malignen Melanoms.